87587-03-9 Usage
Uses
Used in Pharmaceutical Synthesis:
HPTDM is used as a key intermediate in the synthesis of various pharmaceuticals due to its unique chemical structure and reactivity. The presence of the piperidine group and the diazenyl group allows for the creation of a wide range of drug candidates with potential therapeutic applications.
Used in Medical Research:
As a research tool, HPTDM can be utilized in the study of various biological systems and pathways. Its hydroxypyridine group may enable interactions with specific targets, making it a valuable compound for investigating the mechanisms of action of potential drugs and understanding their effects on the human body.
Used in Drug Development:
(E)-[1-(1-hydroxypyridin-2(1H)-ylidene)ethyl]diazenyl(piperidin-1-yl)methanethione's potential to interact with biological systems and its reactivity make it a promising candidate for the development of new pharmaceuticals. Researchers can use HPTDM as a starting point to design and synthesize novel drug molecules with specific therapeutic properties, targeting various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 87587-03-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,7,5,8 and 7 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 87587-03:
(7*8)+(6*7)+(5*5)+(4*8)+(3*7)+(2*0)+(1*3)=179
179 % 10 = 9
So 87587-03-9 is a valid CAS Registry Number.
87587-03-9Relevant academic research and scientific papers
2-Acetylpyridine Thiosemicarbazones. 9. Derivatives of 2-Acetylpyridine 1-Oxide as Potential Antimalarial Agents
Scovill, John P.,Klayman, Daniel L.,Lambros, Chris,Childs, George E.,Notsch, John D.
, p. 87 - 91 (2007/10/02)
In view of the antimalarial activity in mice 2-acetylpyridine thiosemicarbazones, a series of analogues 1-oxides was prepared for evaluation.Their synthesis was achieved by the reaction of 2-acetylpyridine 1-oxide with methylhydrazinecarbodithioate to giv